help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 20, 2007
Endocrinology, doi:10.1210/en.2007-0198
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
149/1/339    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damdimopoulos, A. E.
Right arrow Articles by Gustafsson, J.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damdimopoulos, A. E.
Right arrow Articles by Gustafsson, J.-A.

Submitted on February 14, 2007
Accepted on September 13, 2007

Ligands Differentially Modify the Nuclear Mobility of Estrogen Receptors {alpha} and {beta}

Anastasios E. Damdimopoulos, Giannis Spyrou*, and Jan-Åke Gustafsson

Department of Biosciences and Nutrition at NOVUM, Karolinska Institutet, 14157 Huddinge, Stockholm, Sweden.; Foundation for Biomedical Research, Academy of Athens, 4 Soranou Efesiou, 11527 Athens, Greece

* To whom correspondence should be addressed. E-mail: giannisspyrou{at}bioacademy.gr.

Signaling of nuclear receptors depends on the structure of their ligands, different ligands eliciting different responses. In this study using a comparative analysis, an array of ligands was examined for effects on ER{alpha} and ER{beta} mobility. Our results indicated that these two receptors share similarities in response to some ligands but differ significantly in response to others. Our results suggest that for ER{alpha}, ligands can be classified into three distinct groups: 1. Ligands that do not affect the mobility of the receptor; 2. ligands that cause a moderate effect and 3. ligands that strongly impact mobility of ER{alpha}. Interestingly, we found that for ER{beta} such a classification was not possible as ER{beta} ligands caused a wider spectrum of responses. One of the main differences between the two receptors was the response towards the anti-estrogens ICI and raloxifene which was not attributable to differential sub-nuclear localization or different conformations of helix 12 in the C-terminal domain. We showed that both of these ligands caused a robust phenotype, leading to an almost total immobilization of ER{alpha}, while ER{beta} retained its mobility; we provide evidence that the mobility of the two receptors depends upon the function of the proteosome machinery. This novel finding that ER{beta} retains its mobility in the presence of anti-estrogens, could be important for its ability to regulate genes that do not contain classic ERE sites and do not require DNA binding and could be used in the investigation of ligands that show ER subtype specificity.


Key words: Estrogen Receptor • Ligands • Mobility • Proteasome




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. A. Molenda-Figueira, S. D. Murphy, K. L. Shea, N. K. Siegal, Y. Zhao, J. G. Chadwick Jr., L. A. Denner, and M. J. Tetel
Steroid Receptor Coactivator-1 from Brain Physically Interacts Differentially with Steroid Receptor Subtypes
Endocrinology, October 1, 2008; 149(10): 5272 - 5279.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society